| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/30/2022 | Magenta Therapeutics, Inc. | MGTA | Grant | Common Stock | 3k | $0.94 | $2.8k | | 11/30/2022 |
| 08/01/2022 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 75k | $1.57 | $117.8k | | 08/01/2022 |
| 05/31/2022 | Magenta Therapeutics, Inc. | MGTA | Grant | Common Stock | 3k | $0.99 | $3k | | 05/31/2022 |
| 02/15/2022 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 75k | $3.19 | $239.2k | | 02/15/2022 |
| 09/16/2021 | Magenta Therapeutics, Inc. | MGTA | Sale | Common Stock | 6.1k | $6.73 | $41.1k | | 09/16/2021 |
| 09/14/2021 | Magenta Therapeutics, Inc. | MGTA | Grant | Common Stock | 20k | $0.00 | $0 | | 09/14/2021 |
| 06/14/2021 | Magenta Therapeutics, Inc. | MGTA | Grant | Stock Option (Right to Buy) | 200k | $11.37 | $2.3M | | 06/14/2021 |
| 03/20/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 5.9k | $0.00 | $0 | | 03/20/2021 |
| 03/20/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 4.3k | $0.00 | $0 | | 03/20/2021 |
| 03/16/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 52.6k | $22.89 | $1.2M | | 03/16/2021 |
| 03/16/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Restricted Share Units | 8.8k | $0.00 | $0 | | 03/16/2021 |
| 02/03/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 2.5k | $22.09 | $54.7k | | 02/03/2021 |
| 02/03/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Conversion | Class B Common Shares | 300k | $0.00 | $0 | | 02/03/2021 |
| 02/03/2021 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Conversion | Class A Common Shares | 300k | $0.00 | $0 | | 02/03/2021 |
| 09/10/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 75k | $15.50 | $1.2M | | 09/10/2020 |
| 07/01/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 26.7k | $25.32 | $676.9k | | 07/01/2020 |
| 07/01/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 2.9k | $25.84 | $73.8k | | 07/01/2020 |
| 06/10/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Exercise | Share Option | 13.8k | $1.59 | $21.9k | | 06/10/2020 |
| 06/10/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 13.8k | $25.07 | $344.8k | | 06/10/2020 |
| 04/21/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 955 | $20.44 | $19.5k | | 04/20/2020 |
| 04/21/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 1.6k | $19.56 | $30.6k | | 04/20/2020 |
| 04/20/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 47.4k | $19.06 | $903.9k | | 04/20/2020 |
| 03/13/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 75k | $15.52 | $1.2M | | 03/13/2020 |
| 02/14/2020 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Sale | Class A Common Shares | 59 | $18.58 | $1.1k | | 02/14/2020 |
| 09/17/2019 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 45k | $8.83 | $397.4k | | 09/17/2019 |
| 03/04/2019 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 42k | $17.92 | $752.6k | | 03/04/2019 |
| 09/20/2018 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Grant | Share Option | 45k | $30.93 | $1.4M | | 09/20/2018 |
| 05/29/2018 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Conversion | Class A Common Shares | 6.4k | $0.00 | $0 | | 05/29/2018 |
| 05/29/2018 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Conversion | Class B Common Shares | 48.2k | $0.00 | $0 | | 05/29/2018 |
| 05/29/2018 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Conversion | Series C Preferred Shares | 6.4k | $0.00 | $0 | | 05/29/2018 |
| 02/09/2018 | Kiniksa Pharmaceuticals, Ltd. | KNSA | Purchase | Series C Preferred Shares | 6.4k | $15.64 | $100k | | 05/29/2018 |